Plain-English translation of NCT07182214 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This research study is testing whether a simple blood test can help doctors better detect and evaluate lung cancer. Researchers will collect blood samples from people who have lung nodules found on CT scans and from people without nodules, to look for special markers in the blood that might indicate lung cancer.
Currently, when a CT scan finds a suspicious lung nodule, doctors often need to do surgery or a biopsy to confirm whether it's cancer — which carries risks and exposes many patients without cancer to unnecessary procedures. This study hopes to develop a blood test that could help doctors make better decisions about which nodules need surgery, reducing unnecessary procedures and patient anxiety.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a blood sample taken one time. If you are in the test group (with lung nodules), this will happen before or around the time of any planned medical procedure. You will also be asked to complete a brief questionnaire. The study involves only this single blood draw and questionnaire — no medications to take or multiple visits required.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Taiwan
Sponsor
Pharus Taiwan, Inc.
Enrollment target
~1,340 participants
Started
May 2024
Primary completion
June 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Director of Data Science
Pharus Taiwan, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.